selegiline has been researched along with manganese in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clow, A; Dexter, DT; Glover, V; Hussain, T; Sandler, M; Walker, M | 1 |
Lai, JC; Leung, TK; Lim, L | 1 |
Aguilar, MV; de Bustos, F; González-Muñoz, MJ; Jiménez-Jiménez, FJ; Martínez-Para, MC; Martínez-Salio, A; Mateos-Vega, CJ; Meseguer, I; Molina, JA; Ortí-Pareja, M; Zurdo, M | 1 |
de Oliveira, EF; de Rezende, IC; Fernandes, A; Ponzoni, S | 1 |
4 other study(ies) available for selegiline and manganese
Article | Year |
---|---|
(-)-Deprenyl can induce soluble superoxide dismutase in rat striata.
Topics: Animals; Copper; Corpus Striatum; Cytosol; Enzyme Induction; Male; Manganese; Mitochondria; Rats; Rats, Inbred Strains; Selegiline; Stimulation, Chemical; Superoxide Dismutase; Zinc | 1991 |
The regional distribution of monoamine oxidase activities towards different substrates: effects in rat brain of chronic administration of manganese chloride and of ageing.
Topics: Aging; Animals; Benzylamines; Brain; Chlorides; Clorgyline; Dopamine; Female; Male; Manganese; Manganese Compounds; Monoamine Oxidase; Rats; Selegiline; Serotonin; Tissue Distribution | 1981 |
Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease.
Topics: Age of Onset; Aged; Antiparkinson Agents; Blood Proteins; Copper; Dopamine Agonists; Female; Humans; Iron; Levodopa; Male; Manganese; Metals, Heavy; Middle Aged; Nutritional Status; Parkinson Disease; Reference Values; Selegiline; Spectrophotometry, Atomic; Trace Elements; Vitamin A; Zinc | 1998 |
Manganese neurotoxic time course is not influenced by L-deprenyl systemic treatment: influence of L-deprenyl in manganese neurotoxic time course.
Topics: Animals; Apomorphine; Corpus Striatum; Dopamine Agonists; Immunohistochemistry; Male; Manganese; Monoamine Oxidase Inhibitors; Motor Activity; Neuroprotective Agents; Photomicrography; Rats; Rotation; Selegiline; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2010 |